BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33718231)

  • 1. Identification of Novel Autoantibodies Based on the Human Proteomic Chips and Evaluation of Their Performance in the Detection of Gastric Cancer.
    Cui C; Duan Y; Qiu C; Wang P; Sun G; Ye H; Dai L; Han Z; Song C; Wang K; Shi J; Zhang J
    Front Oncol; 2021; 11():637871. PubMed ID: 33718231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel autoantibodies based on the protein chip encoded by cancer-driving genes in detection of esophageal squamous cell carcinoma.
    Sun G; Ye H; Wang X; Cheng L; Ren P; Shi J; Dai L; Wang P; Zhang J
    Oncoimmunology; 2020 Sep; 9(1):1814515. PubMed ID: 33457096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovering Panel of Autoantibodies for Early Detection of Lung Cancer Based on Focused Protein Array.
    Jiang D; Zhang X; Liu M; Wang Y; Wang T; Pei L; Wang P; Ye H; Shi J; Song C; Wang K; Wang X; Dai L; Zhang J
    Front Immunol; 2021; 12():658922. PubMed ID: 33968062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: A systematic review and meta-analysis.
    Tang ZM; Ling ZG; Wang CM; Wu YB; Kong JL
    PLoS One; 2017; 12(7):e0182117. PubMed ID: 28750095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies as diagnostic biomarkers for lung cancer: A systematic review.
    Yang B; Li X; Ren T; Yin Y
    Cell Death Discov; 2019; 5():126. PubMed ID: 31396403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and evaluation of novel serum autoantibody biomarkers for early diagnosis of gastric cancer and precancerous lesion.
    Zhu Q; He P; Zheng C; Chen Z; Qi S; Zhou D; Li Y; Ouyang Q; Zi H; Tang H; Xing J; Xie Y; Zhu S; Ren J; Huang J
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8369-8378. PubMed ID: 37079049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using a panel of multiple tumor-associated antigens to enhance autoantibody detection for immunodiagnosis of gastric cancer.
    Wang S; Qin J; Ye H; Wang K; Shi J; Ma Y; Duan Y; Song C; Wang X; Dai L; Wang K; Wang P; Zhang J
    Oncoimmunology; 2018; 7(8):e1452582. PubMed ID: 30221047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Proteome Microarray identifies autoantibodies to tumor-associated antigens as serological biomarkers for the diagnosis of hepatocellular carcinoma.
    Yang Q; Ye H; Sun G; Wang K; Dai L; Qiu C; Shi J; Zhu J; Wang X; Wang P
    Mol Oncol; 2023 May; 17(5):887-900. PubMed ID: 36587394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel tumor-associated antigens and evaluation of a panel of autoantibodies in detecting oral cancer.
    Xie W; Sun G; Xia J; Chen H; Wang C; Lin J; Wang P
    BMC Cancer; 2023 Aug; 23(1):802. PubMed ID: 37641028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibody signatures discovered by HuProt protein microarray to enhance the diagnosis of lung cancer.
    Wang Y; Li J; Zhang X; Liu M; Ji L; Yang T; Wang K; Song C; Wang P; Ye H; Shi J; Dai L
    Clin Immunol; 2023 Jan; 246():109206. PubMed ID: 36528251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel autoantibody signatures for enhanced clinical diagnosis of pancreatic ductal adenocarcinoma.
    Li T; Xia J; Yun H; Sun G; Shen Y; Wang P; Shi J; Wang K; Yang H; Ye H
    Cancer Cell Int; 2023 Nov; 23(1):273. PubMed ID: 37974212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumor-associated autoantibodies as novel diagnostic biomarkers in pancreatic adenocarcinoma.
    Zhuang L; Huang C; Ning Z; Yang L; Zou W; Wang P; Cheng CS; Meng Z
    Int J Cancer; 2023 Mar; 152(5):1013-1024. PubMed ID: 36274627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and Validation of Serum Autoantibodies Against Tumor-Associated Antigens as Biomarkers in Gastric Adenocarcinoma Based on the Focused Protein Arrays.
    Yang Q; Qin J; Sun G; Qiu C; Jiang D; Ye H; Wang X; Dai L; Zhu J; Wang P; Zhang J
    Clin Transl Gastroenterol; 2020 Dec; 12(1):e00284. PubMed ID: 33346593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of autoantibodies combined with tumor markers in the detection of lung cancer.
    Mu Y; Li J; Xie F; Xu L; Xu G
    J Clin Lab Anal; 2022 Aug; 36(8):e24504. PubMed ID: 35596744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using protein microarray to identify and evaluate autoantibodies to tumor-associated antigens in ovarian cancer.
    Ma Y; Wang X; Qiu C; Qin J; Wang K; Sun G; Jiang D; Li J; Wang L; Shi J; Wang P; Ye H; Dai L; Jiang BH; Zhang J
    Cancer Sci; 2021 Feb; 112(2):537-549. PubMed ID: 33185955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies against tumor-associated antigens in sputum as biomarkers for lung cancer.
    Li N; Holden VK; Deepak J; Todd NW; Jiang F
    Transl Oncol; 2021 Feb; 14(2):100991. PubMed ID: 33333369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using Proteome Microarray and Gene Expression Omnibus Database to Screen Tumour-Associated Antigens to Construct the Optimal Diagnostic Model of Oesophageal Squamous Cell Carcinoma.
    Sun G; Ye H; Yang Q; Zhu J; Qiu C; Shi J; Dai L; Wang K; Zhang J; Wang P
    Clin Oncol (R Coll Radiol); 2023 Oct; 35(10):e582-e592. PubMed ID: 37433700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and validation of an immunodiagnostic model for prediction of breast cancer.
    Qiu C; Wang P; Wang B; Shi J; Wang X; Li T; Qin J; Dai L; Ye H; Zhang J
    Oncoimmunology; 2020; 9(1):1682382. PubMed ID: 32002291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral Blood Autoantibodies Against to Tumor-Associated Antigen Predict Clinical Outcome to Immune Checkpoint Inhibitor-Based Treatment in Advanced Non-Small Cell Lung Cancer.
    Zhou J; Zhao J; Jia Q; Chu Q; Zhou F; Chu X; Zhao W; Ren S; Zhou C; Su C
    Front Oncol; 2021; 11():625578. PubMed ID: 33816260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-dimensional immunoproteomics coupled with in vitro recapitulation of oncogenic NRAS
    Belousov PV; Afanasyeva MA; Gubernatorova EO; Bogolyubova AV; Uvarova AN; Putlyaeva LV; Ramanauskaite EM; Kopylov AT; Demin DE; Tatosyan KA; Ustiugova AS; Prokofjeva MM; Lanshchakov KV; Vanushko VE; Zaretsky AR; Severskaia NV; Dvinskikh NY; Abrosimov AY; Kuprash DV; Schwartz AM
    Cancer Lett; 2019 Dec; 467():96-106. PubMed ID: 31326556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.